DRUG offering history
Every offering-related filing in BRIGHT MINDS BIOSCIENCES INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 173 filings back to Oct 6, 2020.
| Date | Filing | What it means | |
|---|---|---|---|
| Jan 9, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 7, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 7, 2026 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 7, 2026 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Sep 2, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 26, 2025 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
| Feb 14, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 14, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 5, 2025 | F-3 → | REGISTERED | F-3 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
DRUG offering FAQ
When did DRUG last execute an offering?
Per SEC filings, BRIGHT MINDS BIOSCIENCES INC.'s most recent priced offering document is a 424B5 filed 2026-01-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did DRUG last announce or register an offering?
The most recent registration is a F-3 filed 2025-08-26. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.